E-LIB Suche - Ergebnisse für: Lafayette, Richard

1

The role of BAFF and APRIL in IgA nephropathy: pathogenic m..:

Cheung, Chee Kay ; Barratt, Jonathan ; Liew, Adrian...
Frontiers in Nephrology. 3 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

2

WCN24-2099 BASELINE CHARACTERISTICS OF THE ALIGN TRIAL: A P..:

Heerspink, Hiddo J.L. ; Jardine, Meg ; Kohan, Donald E....
Kidney International Reports. 9 (2024) 4 - p. S183 , 2024

Link: https://doi.org/10.1016/..

3

A phase 2b, randomized, double-blind, placebo-controlled, c..:

Lafayette, Richard ; Barbour, Sean ; Israni, Rubeen...
Kidney International. 105 (2024) 6 - p. 1306-1315 , 2024

Link: https://doi.org/10.1016/..

4

WCN24-1159 TREATMENT PATTERNS IN PATIENTS WITH IMMUNOGLOBUL..:

Smeets, Serge ; Lafayette, Richard ; Tang, Sydney...
Kidney International Reports. 9 (2024) 4 - p. S154-S155 , 2024

Link: https://doi.org/10.1016/..

5

WCN24-342 ATACICEPT IN IGA NEPHROPATHY: CONTINUED PROTECTIV..:

Barratt, Jonathan ; Maes, Bart ; Israni, Rubeen...
Kidney International Reports. 9 (2024) 4 - p. S134 , 2024

Link: https://doi.org/10.1016/..

6

#123 Impact of atacicept on hematuria in IGA nephropathy: p..:

Floege, Jürgen ; Barratt, Jonathan ; Maes, Bart...
Nephrology Dialysis Transplantation. 39 (2024) Supplement_1 - p. , 2024

Link: https://doi.org/10.1093/..

7

WCN24-1688 SELF-REPORTED QUALITY OF LIFE IN COMPLEMENT 3 GL..:

Lafayette, Richard ; Sidhu, Raisa ; Proudfoot, Clare...
Kidney International Reports. 9 (2024) 4 - p. S60-S61 , 2024

Link: https://doi.org/10.1016/..

8

#812 Phase 2b ORIGIN study open label extension with atacic..:

Lafayette, Richard ; Maes, Bart ; Israni, Rubeen...
Nephrology Dialysis Transplantation. 39 (2024) Supplement_1 - p. , 2024

Link: https://doi.org/10.1093/..

9

Growth in children with nephrotic syndrome: a post hoc anal..:

Maniar, Aesha ; Gipson, Debbie S. ; Brady, Tammy...
Pediatric Nephrology. , 2024

Link: https://doi.org/10.1007/..

10

WCN24-1674 NEFECON TREATMENT RESPONSE IN ASIAN AND WHITE PA..:

Barratt, Jonathan ; Kristensen, Jens ; Stone, Andrew...
Kidney International Reports. 9 (2024) 4 - p. S169-S170 , 2024

Link: https://doi.org/10.1016/..

11

WCN24-1777 NEFECON TREATMENT PROVIDES KIDNEY BENEFITS FOR P..:

Barratt, Jonathan ; Kristensen, Jens ; Stone, Andrew...
Kidney International Reports. 9 (2024) 4 - p. S174-S175 , 2024

Link: https://doi.org/10.1016/..

12

WCN24-1774 eGFR DECLINE IN PATIENTS WITH IgAN TREATED WITH ..:

Lafayette, Richard ; Kristensen, Jens ; Stone, Andrew...
Kidney International Reports. 9 (2024) 4 - p. S173-S174 , 2024

Link: https://doi.org/10.1016/..

13

WCN24-1799 HEMATURIA RESOLUTION WITH THE APRIL-BLOCKING MON..:

Barratt, Jonathan ; Lafayette, Richard ; Suzuki, Hitoshi...
Kidney International Reports. 9 (2024) 4 - p. S125-S126 , 2024

Link: https://doi.org/10.1016/..

14

WCN24-1163 TREATMENT GOALS FROM THE PERSPECTIVE OF IMMUNOGL..:

George, Aneesh Thomas ; Lafayette, Richard ; Tang, Sydney...
Kidney International Reports. 9 (2024) 4 - p. S155 , 2024

Link: https://doi.org/10.1016/..

15

WCN24-1776 NEFECON EFFECT ON QUALITY OF LIFE IN PATIENTS WI..:

Barratt, Jonathan ; Kristensen, Jens ; Stone, Andrew...
Kidney International Reports. 9 (2024) 4 - p. S174 , 2024

Link: https://doi.org/10.1016/..